As of Feb 23
| -0.06 / -2.51%|
The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 2.00, with a high estimate of 10.00 and a low estimate of 1.50. The median estimate represents a -14.16% decrease from the last price of 2.33.
The current consensus among 8 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.